Cargando…

Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression

BACKGROUND: This study aimed to evaluate the value of urinary angiostatin levels for assessing disease severity and progression of IgA nephropathy (IgAN). METHODS: Urinary angiostatin was identified as one of the distinct proteins in samples of patients with IgAN analyzed by Raybiotech protein array...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yuan-Yuan, Bu, Ru, Cai, Guang-Yan, Zhang, Xue-Guang, Duan, Shu-Wei, Wu, Jie, Wu, Di, Chen, Xiang-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446319/ https://www.ncbi.nlm.nih.gov/pubmed/30943905 http://dx.doi.org/10.1186/s12882-019-1305-2

Ejemplares similares

Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
por: Mok, Chi Chiu, et al.
Publicado: (2018)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
por: Cheng, Yuan, et al.
Publicado: (2022)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

Beneficial Effects of Caloric Restriction on Chronic Kidney Disease in Rodent Models: A Meta-Analysis and Systematic Review
por: Xu, Xiao-meng, et al.
Publicado: (2015)

Circulating angiostatin serum level in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2017)

Effect of Angiostatin on Liver Metastasis of Pancreatic Cancer in Hamsters
por: Yanagi, Ken, et al.
Publicado: (2000)

Embryonic Stem Cells-loaded Gelatin Microcryogels Slow Progression of Chronic Kidney Disease
por: Geng, Xiao-Dong, et al.
Publicado: (2016)

Progress of small ubiquitin-related modifiers in kidney diseases
por: Li, Ou, et al.
Publicado: (2019)

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen
por: Heidtmann, H-H, et al.
Publicado: (1999)

Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006)

A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin
por: Parris, George E.
Publicado: (2015)

Tranexamic acid reduces endometrial cancer effects through the production of angiostatin
por: Hiramoto, Keiichi, et al.
Publicado: (2022)

Angiomotin: An Angiostatin Binding Protein That Regulates Endothelial Cell Migration and Tube Formation
por: Troyanovsky, Boris, et al.
Publicado: (2001)

Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators
por: de Groot-Besseling, Renate RJ, et al.
Publicado: (2006)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2018)

Urinary Peptidomic Biomarkers in Kidney Diseases
por: Sirolli, Vittorio, et al.
Publicado: (2019)

Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy
por: Liang, Shuang, et al.
Publicado: (2017)

Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector
por: Shyong, Mong-Ping, et al.
Publicado: (2007)

Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity
por: Mogues, Tirsit, et al.
Publicado: (2004)

Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease
por: Segarra-Medrano, Alfons, et al.
Publicado: (2019)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Research Progress on the Role of Inflammasomes in Kidney Disease
por: Chi, Kun, et al.
Publicado: (2020)

Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol
por: Liang, Shuang, et al.
Publicado: (2018)

Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
por: Albini, Adriana, et al.
Publicado: (2009)

Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011)

Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration
por: Radziwon-Balicka, Aneta, et al.
Publicado: (2013)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

New urinary biomarkers for diabetic kidney disease
por: Wang, Cheng, et al.
Publicado: (2013)

Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease
por: Charlton, Jennifer R., et al.
Publicado: (2023)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
por: Brauer, Rena, et al.
Publicado: (2011)

Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin(4.5), induces fetal microphthalmia
por: Rutland, Catrin S., et al.
Publicado: (2009)

Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017)

Urinary Biomarkers in Monitoring the Progression and Treatment of Autosomal Dominant Polycystic Kidney Disease—The Promised Land?
por: Pana, Camelia, et al.
Publicado: (2023)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection
por: Wang, Si-Yang, et al.
Publicado: (2016)

Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases
por: Gámez-Valero, Ana, et al.
Publicado: (2015)

Angiostatin-mediated Suppression of Cancer Metastases by Primary Neoplasms Engineered to Produce Granulocyte/Macrophage Colony–stimulating Factor
por: Dong, Zhongyun, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_tirn51eak6s87njeb24c1hiosa